Epidemiological studies on cognition and the omega-6/omega-3 balance

World Review of Nutrition and Dietetics

Volumn 102, Issue , 2011, Pages 92-97

  Féart, Catherine ^a,b   Barberger Gateau, Pascale ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTICLE; BRAIN; COGNITION; DEMENTIA; DIET; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG POTENTIATION; EPIDEMIOLOGY; FAT INTAKE; FEEDING BEHAVIOR; HEALTH FOOD; HUMAN; METABOLISM; NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ANTIOXIDANTS; BRAIN; COGNITION; DEMENTIA; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; DRUG SYNERGISM; EPIDEMIOLOGIC STUDIES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FOOD HABITS; HEALTH FOOD; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 80052065971     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000327796     Document Type: Article

References (56)

1. Ritchie K, Lovestone S: The dementias. Lancet 2002;360:1759-1766.
2. Lobo A, Launer LJ, Fratiglioni L, et al: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurol Dis Elderly Res Group. Neurology 2000;54:S4-S9.
3. Wimo A, Jonsson L, Winblad B: An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord 2006;21:175-181.
4. Lambert JC, Heath S, Even G, et al: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-1099.
5. Middleton LE, Yaffe K: Targets for the prevention of dementia. J Alzheimers Dis 2010;20:915-924.
6. Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet 2006;368:387-403.
7. Morris MC: The role of nutrition in Alzheimer's disease: epidemiological evidence. Eur J Neurol 2009;16(Suppl 1):1-7.
8. Brayne C: The elephant in the room - healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 2007;8:233-239.
9. Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, et al: IANA Task Force on Nutrition and Cognitive Decline with Aging. J Nutr Health Aging 2007;11:132-152.
10. Gomez-Pinilla F: Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008;9:568-578.
11. Luchsinger JA, Noble JM, Scarmeas N: Diet and Alzheimer's disease. Curr Neurol Neurosci Rep 2007;7:366-372.
12. Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P: Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009;48:239-256.
13. Joseph J, Cole G, Head E, Ingram D: Nutrition, brain aging, and neurodegeneration. J Neurosci 2009;29:12795-12801.
14. Simopoulos A P, Leaf A, Salem N Jr: Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000;63:119-121.
15. Martin A: The 'apports nutritionnels conseilles (ANC) ' for the French population. Reprod Nutr Dev 2001;41:119-128.
16. Burdge GC, Calder PC: Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005;45:581-597.
17. Imre S, Firbas JH, Noble RC: Reduced lipid peroxidation capacity and desaturation as biochemical markers of aging. Arch Gerontol Geriatr 2000;31:5-12.
18. Bourre JM: Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 2004;8:163-174.
19. Rapoport SI, Rao JS, Igarashi M: Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot Essent Fatty Acids 2007;77:251-61.
20. Innis SM: Dietary (n-3) fatty acids and brain development. J Nutr 2007;137:855-859.
21. Hooijmans CR, Kiliaan AJ: Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 2008;585:176-196.
22. Schmitz G, Ecker J: The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008;47:147-55.
23. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70:560S-569S.
24. Sampath H, Ntambi JM: Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 2004;62:333-339.
25. Lukiw WJ, Bazan NG: Docosahexaenoic acid and the aging brain. J Nutr 2008;138:2510-2514.
26. Calon F, Cole G: Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 2007;77:287-293.
27. Floyd RA, Hensley K: Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002;23:795-807.
28. Jicha GA, Markesbery WR: Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging 2010;5:45-61.
29. Cederholm T, Palmblad J: Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care 2010;13:150-155.
30. Cole GM, Frautschy SA: DHA may prevent age-related dementia. J Nutr 2010;140:869-874.
31. Fotuhi M, Mohassel P, Yaffe K: Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009;5:140-152.
32. Albanese E, Dangour AD, Uauy R, et al: Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study. Am J Clin Nutr 2009;90:392-400.
33. Devore EE, Grodstein F, van Rooij FJ, et al: Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009;90:170-176.
34. van de Rest O, Spiro A 3rd, Krall-Kaye E, Geleijnse JM, de Groot LC, Tucker KL: Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study. J Nutr 2009;139:2329-2336.
35. Feart C, Samieri C, Barberger-Gateau P: Diet and Alzheimer's disease: new evidence from epidemiological studies; in Ramassamy C, Bastianetto S (eds): Recent Advances on Nutrition in the Prevention of Alzheimer's Disease. Kerala, Research Signpost/Transworld Research Network, 2009.
36. Welch AA, Bingham SA, Ive J, et al: Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr 2006;84:1330-1339.
37. Arab L: Biomarkers of fat and fatty acid intake. J Nutr 2003;133(Suppl 3):925S-932S.
38. Samieri C, Feart C, Letenneur L, et al: Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008;88:714-721.
39. Samieri C, Feart C, Proust-Lima C, et al: Omega-3 fatty acids and cognitive decline: modulation by ApoE epsilon 4 allele and depression. Neurobiol Aging 2010 Jun. 4. [Epub ahead of print].
40. Heude B, Ducimetiere P, Berr C: Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 2003;77:803-808.
41. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, et al: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006;63:1402-1408.
42. van de Rest O, Geleijnse JM, Kok FJ, et al: Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008;71:430-438.
43. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM: Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008;11:75-83.
44. Dangour AD, Allen E, Elbourne D, et al: Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010;91:1725-1732.
45. Berr C, Portet F, Carriere I, et al: Olive oil and cognition: results from the threecity study. Dement Geriatr Cogn Disord 2009;28:357-364.
46. Berr C, Akbaraly T, Arnaud J, Hininger I, Roussel AM, Barberger Gateau P: Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J Nutr Health Aging 2009;13:14-18.
47. Barberger-Gateau P, Raffaitin C, Letenneur L, et al: Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007;69:1921-1930.
48. Huang TL, Zandi P P, Tucker KL, et al: Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 2005;65:1409-1414.
49. Whalley LJ, Deary IJ, Starr JM, et al: n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008;87:449-454.
50. Eskelinen MH, Ngandu T, Helkala EL, et al: Fat intake at midlife and cognitive impairment later in life: a populationbased CAIDE study. Int J Geriatr Psychiatry 2008;23:741-747.
51. Laitinen MH, Ngandu T, Rovio S, et al: Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord 2006;22:99-107.
52. Jacques P F, Tucker KL: Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr 2001;73:1-2.
53. Kant AK: Dietary patterns and health outcomes. J Am Diet Assoc 2004;104:615-35.
54. Feart C, Samieri C, Barberger-Gateau P: Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 2010;13:14-18.
55. Feart C, Samieri C, Rondeau V, et al: Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009;302:638-648.
56. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA: Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006;59:912-921.